SCHEMBL3564100

SCHEMBL3564100

CN(C)CCOc1c(-c2ccccc2)[nH]c2c(Br)cc(Cl)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.40
PDE10A Q9Y233 1/20 0.40
MAPT P10636 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
CSF1R P07333 1/20 0.36
TUBB4A P04350 2/20 0.36
TUBB P07437 2/20 0.36
TUBA3C P0DPH7 2/20 0.36
TUBA1B P68363 2/20 0.36
TUBA4A P68366 2/20 0.36
TUBB4B P68371 2/20 0.36
TUBB3 Q13509 2/20 0.36
TUBB2A Q13885 2/20 0.36
TUBB8 Q3ZCM7 2/20 0.36
TUBA3E Q6PEY2 2/20 0.36
TUBA1A Q71U36 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558001 0.88 HTR7 (0.42) HTR7KDM4EALDH1A1SMN1; SMN2HTR2A
SCHEMBL3558501 0.88 PDE10A (0.41) HTR7PDE10AMAPTKDM4EALDH1A1
SCHEMBL3553775 0.81 MAPT (0.44) HTR7MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL3553981 0.80 PDE10A (0.59) HTR7PDE10AHTR2AHTR2CTUBB4A
SCHEMBL3555171 0.78 PDE10A (0.50) HTR7PDE10AKDM4EALDH1A1HTR2A
SCHEMBL3565415 0.75 TUBB4A (0.49) HTR7PDE10AKDM4EALDH1A1HTR2A
SCHEMBL3555901 0.75 HTR2A (0.58) HTR7ALDH1A1HTR2AHTR2CESR1
SCHEMBL855097 0.72 TNKS (0.50) HTR7KDM4EALDH1A1SMN1; SMN2HTR2A
SCHEMBL7154224 0.72 ESR1 (0.37) HTR7MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL14953594 0.71 KDM4E (0.41) HTR7KDM4EALDH1A1SMN1; SMN2CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR7 51/4885PDE10A 2655/4885MAPT 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.